These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7215417)

  • 1. Pharmacokinetics of oral timolol studied by mass fragmentography.
    Fourtillan JB; Courtois P; Lefebvre MA; Girault J
    Eur J Clin Pharmacol; 1981 Feb; 19(3):193-6. PubMed ID: 7215417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
    Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO
    Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.
    Mäntylä R; Männistö P; Nykänen S; Koponen A; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 24(2):227-30. PubMed ID: 6840172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass fragmentographic determination of timolol in human plasma and urine.
    Fourtillan JB; Lefebvre MA; Girault J; Courtois P
    J Pharm Sci; 1981 May; 70(5):573-5. PubMed ID: 7241368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of ocular timolol.
    Alvan G; Calissendorff B; Seideman P; Widmark K; Widmark G
    Clin Pharmacokinet; 1980; 5(1):95-100. PubMed ID: 7363532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary column GLC-mass spectrometric assay with selected-ion monitoring for timolol and [13C3]timolol in human plasma.
    Carlin JR; Walker RW; Davies RO; Ferguson RT; Vandenheuvel WJ
    J Pharm Sci; 1980 Oct; 69(10):1111-5. PubMed ID: 7420275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.
    Ishizaki T; Tawara K; Oyama Y; Nakaya H
    J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma timolol levels after oral and intravenous administration.
    Else OF; Sorenson H; Edwards IR
    Eur J Clin Pharmacol; 1978 Dec; 14(6):431-4. PubMed ID: 738350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of timolol in man.
    Vermeij P; el-Sherbini-Schepers M; van Zwieten PA
    J Pharm Pharmacol; 1978 Jan; 30(1):53-5. PubMed ID: 22728
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic differences between single and multiple oral dosing with the guidance for beta-adrenoceptor blockade assessment.
    Ishizaki T; Tawara K
    Cardiology; 1979; 64 Suppl 1():25-43. PubMed ID: 42487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of the systemic bioavailability of timolol in man.
    El-Rashidy R
    Biopharm Drug Dispos; 1981; 2(2):197-202. PubMed ID: 7248483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timolol kinetics in chronic renal insufficiency.
    Lowenthal DT; Pitone JM; Affrime MB; Shirk J; Busby P; Kim KE; Nancarrow J; Swartz CD; Onesti G
    Clin Pharmacol Ther; 1978 May; 23(5):606-15. PubMed ID: 639436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers.
    Vedin JA; Kristianson JK; Wilhelmsson CE
    Eur J Clin Pharmacol; 1982; 23(1):43-7. PubMed ID: 7128671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T; Ohnishi A; Sasaki T; Kushida K; Horai Y; Chiba K; Suganuma T
    Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological disposition and metabolism of timolol in man and laboratory animals.
    Tocco DJ; Duncan AE; Delauna FA; Hucker HB; Gruber VF; Vandenheuvel WJ
    Drug Metab Dispos; 1975; 3(5):361-70. PubMed ID: 241617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of stable isotope labeling and liquid chromatography-tandem mass spectrometry techniques to simultaneously determine the oral and ophthalmic bioavailability of timolol in dogs.
    Gilbert JD; Olah TV; Morris MJ; Bortnick A; Brunner J
    J Chromatogr Sci; 1998 Apr; 36(4):163-8. PubMed ID: 9563202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The bioavailability of transdermal therapeutic system of timolol].
    Ji XF; Ping QN; Liu GJ; Yu ST
    Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active transport of beta-adrenergic blocking agents in the anterior uvea of albino rabbit.
    Matsumoto S; Araie M; Takase M
    Jpn J Ophthalmol; 1986; 30(4):339-50. PubMed ID: 2884338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.